Boryung Balance Sheet Health
Financial Health criteria checks 5/6
Boryung has a total shareholder equity of ₩549.3B and total debt of ₩202.3B, which brings its debt-to-equity ratio to 36.8%. Its total assets and total liabilities are ₩915.5B and ₩366.3B respectively. Boryung's EBIT is ₩67.7B making its interest coverage ratio 7.8. It has cash and short-term investments of ₩20.1B.
Key information
36.8%
Debt to equity ratio
₩202.32b
Debt
| Interest coverage ratio | 7.8x |
| Cash | ₩20.05b |
| Equity | ₩549.25b |
| Total liabilities | ₩366.26b |
| Total assets | ₩915.51b |
Recent financial health updates
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08
Recent updates
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)
Apr 28Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend
Feb 27Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 09Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?
Jan 25Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?
Jan 10If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns
Dec 23Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?
Nov 23Financial Position Analysis
Short Term Liabilities: A003850's short term assets (₩377.7B) exceed its short term liabilities (₩201.1B).
Long Term Liabilities: A003850's short term assets (₩377.7B) exceed its long term liabilities (₩165.2B).
Debt to Equity History and Analysis
Debt Level: A003850's net debt to equity ratio (33.2%) is considered satisfactory.
Reducing Debt: A003850's debt to equity ratio has increased from 33.6% to 36.8% over the past 5 years.
Debt Coverage: A003850's debt is well covered by operating cash flow (20.9%).
Interest Coverage: A003850's interest payments on its debt are well covered by EBIT (7.8x coverage).